Enlivex Therapeutics (ENLV)

• Market cap: $240M
• 1 day: -2.88%
• 5 days: -7.34%
• 1 month: 50.3%
• 3 months: -3.81%
• 6 months: -34.42%
• Year to date: 33.79%
• 1 year: -9.01%
• 5 years: -92.05%
• 10 years: -99.3%
• Sector: Healthcare
• Industry: Biotechnology

About: Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Employees: 36